(Q38097736)

28 August 2017

title

Traditional and novel methods to assess and prevent chemotherapy-related cardiac dysfunction noninvasively (English)

1 reference

28 August 2017

1 reference

Ronald G Schwartz

1

1 reference

28 August 2017

Diwakar Jain

series ordinal

2

1 reference

28 August 2017

Eugene Storozynsky

series ordinal

3

1 reference

28 August 2017

publication date

1 June 2013

1 reference

Journal of Nuclear Cardiology

28 August 2017

published in

1 reference

28 August 2017

volume

20

1 reference

28 August 2017

issue

3

1 reference

28 August 2017

page(s)

443-464

1 reference

Cardiovascular complications of cancer therapy: incidence, pathogenesis, diagnosis, and management

28 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS12350-013-9707-1

American Society of Clinical Oncology clinical evidence review on the ongoing care of adult cancer survivors: cardiac and pulmonary late effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12350-013-9707-1

Initial assessment, surveillance, and management of blood pressure in patients receiving vascular endothelial growth factor signaling pathway inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12350-013-9707-1

A clinicopathologic analysis of adriamycin cardiotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12350-013-9707-1

Serial assessment of doxorubicin cardiotoxicity with quantitative radionuclide angiocardiography

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12350-013-9707-1

Serial radionuclide assessment of doxorubicin cardiotoxicity in cancer patients with abnormal baseline resting left ventricular performance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12350-013-9707-1

Congestive heart failure and left ventricular dysfunction complicating doxorubicin therapy. Seven-year experience using serial radionuclide angiocardiography

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12350-013-9707-1

Doxorubicin cardiotoxicity: prevention of congestive heart failure with serial cardiac function monitoring with equilibrium radionuclide angiocardiography in the current era.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12350-013-9707-1

Cardiac toxicity 4 to 20 years after completing anthracycline therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12350-013-9707-1

Late cardiac effects of doxorubicin therapy for acute lymphoblastic leukemia in childhood

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12350-013-9707-1

Chronic progressive cardiac dysfunction years after doxorubicin therapy for childhood acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12350-013-9707-1

Efficacy and cost of cardiac monitoring in patients receiving doxorubicin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12350-013-9707-1

Cardiac management during adjuvant trastuzumab therapy: recommendations of the Canadian Trastuzumab Working Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12350-013-9707-1

Prospective evaluation of doxorubicin cardiotoxicity by rest and exercise radionuclide angiography

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12350-013-9707-1

Variability of left ventricular ejection fraction and volumes with quantitative gated SPECT: influence of algorithm, pixel size and reconstruction parameters in small and normal-sized hearts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12350-013-9707-1

ACCF/ASNC/ACR/AHA/ASE/SCCT/SCMR/SNM 2009 Appropriate Use Criteria for Cardiac Radionuclide Imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12350-013-9707-1

Prognostic value of left ventricular end-systolic volume index as a predictor of heart failure hospitalization in stable coronary artery disease: data from the Heart and Soul Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12350-013-9707-1

Reproducibility of echocardiographic techniques for sequential assessment of left ventricular ejection fraction and volumes: application to patients undergoing cancer chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12350-013-9707-1

Is echocardiography reliable for monitoring the adverse cardiac effects of chemotherapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12350-013-9707-1

Prolongation of isovolumetric relaxation time as assessed by Doppler echocardiography predicts doxorubicin-induced systolic dysfunction in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12350-013-9707-1

Tissue Doppler imaging and conventional echocardiography after anthracycline treatment in adults: early and late alterations of left ventricular function during a prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12350-013-9707-1

Early reduction in left ventricular contractile reserve detected by dobutamine stress echo predicts high-dose chemotherapy-induced cardiac toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12350-013-9707-1

Screening adult survivors of childhood cancer for cardiomyopathy: comparison of echocardiography and cardiac magnetic resonance imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12350-013-9707-1

Prognostic value of myocardial 123I-metaiodobenzylguanidine (MIBG) parameters in patients with heart failure: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12350-013-9707-1

Imaging cardiac neuronal function and dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12350-013-9707-1

Myocardial iodine-123 meta-iodobenzylguanidine imaging and cardiac events in heart failure. Results of the prospective ADMIRE-HF (AdreView Myocardial Imaging for Risk Evaluation in Heart Failure) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12350-013-9707-1

Assessment of cardiac sympathetic neuronal function using PET imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12350-013-9707-1

Doxorubicin-induced apoptosis: implications in cardiotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12350-013-9707-1

Doxorubicin-induced cardiomyopathy from the cardiotoxic mechanisms to management

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12350-013-9707-1

Assessment of fatty acid metabolism in taxan-induced myocardial damage with iodine-123 BMIPP SPECT: Comparative study with myocardial perfusion, left ventricular function, and histopathological findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12350-013-9707-1

111Indium-trastuzumab visualises myocardial human epidermal growth factor receptor 2 expression shortly after anthracycline treatment but not during heart failure: a clue to uncover the mechanisms of trastuzumab-related cardiotoxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12350-013-9707-1

Role of biomarkers in chemotherapy-induced cardiotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12350-013-9707-1

Protective effects of carvedilol against anthracycline-induced cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12350-013-9707-1

Serial measurements of cardiac biomarkers in patients after allogeneic hematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12350-013-9707-1

Biochemical markers for prediction of chemotherapy-induced cardiotoxicity: systematic review of the literature and recommendations for use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12350-013-9707-1

Strain rate imaging detects early cardiac effects of pegylated liposomal Doxorubicin as adjuvant therapy in elderly patients with breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12350-013-9707-1

Subclinical anthracycline- and trastuzumab-induced cardiotoxicity in the long-term follow-up of asymptomatic breast cancer survivors: a speckle tracking echocardiographic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12350-013-9707-1

Early detection and prediction of cardiotoxicity in chemotherapy-treated patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12350-013-9707-1

Assessment of echocardiography and biomarkers for the extended prediction of cardiotoxicity in patients treated with anthracyclines, taxanes, and trastuzumab

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12350-013-9707-1

Non-invasive imaging and monitoring cardiotoxicity of cancer therapeutic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12350-013-9707-1

Radionuclide ventriculography detects early anthracycline cardiotoxicity in children with Hodgkin lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12350-013-9707-1

Long-term prospective follow-up study of cardiac function after cardiotoxic therapy for malignancy in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12350-013-9707-1

Cardiac outcomes in a cohort of adult survivors of childhood and adolescent cancer: retrospective analysis of the Childhood Cancer Survivor Study cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12350-013-9707-1

Role of imaging in cardiac stem cell therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12350-013-9707-1

ACCF/ACR/SCCT/SCMR/ASNC/NASCI/SCAI/SIR 2006 appropriateness criteria for cardiac computed tomography and cardiac magnetic resonance imaging: a report of the American College of Cardiology Foundation Quality Strategic Directions Committee Appropriate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12350-013-9707-1

Cardiac magnetic resonance monitors reversible and irreversible myocardial injury in myocarditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12350-013-9707-1

Delayed contrast enhancement cardiac magnetic resonance imaging in trastuzumab induced cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12350-013-9707-1

Novel approach to early detection of doxorubicin cardiotoxicity by gadolinium-enhanced cardiovascular magnetic resonance imaging in an experimental model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12350-013-9707-1

A single breath-hold multiecho T2* cardiovascular magnetic resonance technique for diagnosis of myocardial iron overload.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12350-013-9707-1

A molecular MRI probe to detect treatment of cardiac apoptosis in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12350-013-9707-1

Complementary prognostic values of stress myocardial perfusion and late gadolinium enhancement imaging by cardiac magnetic resonance in patients with known or suspected coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12350-013-9707-1

Prognostic significance of myocardial fibrosis quantification by histopathology and magnetic resonance imaging in patients with severe aortic valve disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12350-013-9707-1

Myocardial Scar Visualized by Cardiovascular Magnetic Resonance Imaging Predicts Major Adverse Events in Patients With Hypertrophic Cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12350-013-9707-1

Detection of myocardial damage in patients with sarcoidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12350-013-9707-1

Acute doxorubicin cardiotoxicity is associated with miR-146a-induced inhibition of the neuregulin-ErbB pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12350-013-9707-1

Downregulation of doxorubicin-induced myocardial apoptosis accompanies postnatal heart maturation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12350-013-9707-1

Mechanism of doxorubicin-induced inhibition of sarcoplasmic reticulum Ca(2+)-ATPase gene transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12350-013-9707-1

Cancer genetics and the cardiotoxicity of the therapeutics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12350-013-9707-1

Monitoring chemotherapy-induced cardiotoxicity: role of cardiac nuclear imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12350-013-9707-1

Fluorouracil cardiotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12350-013-9707-1

Pharmacogenomic Prediction of Anthracycline-Induced Cardiotoxicity in Children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12350-013-9707-1

Occurrence and Frequency of Arrhythmias in Hypertrophic Cardiomyopathy in Relation to Delayed Enhancement on Cardiovascular Magnetic Resonance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12350-013-9707-1

Prognosis Assessment of Cardiac Involvement in Systemic AL Amyloidosis by Magnetic Resonance Imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12350-013-9707-1

EANM/ESC guidelines for radionuclide imaging of cardiac function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12350-013-9707-1

Guidelines for cardiac monitoring of children during and after anthracycline therapy: report of the Cardiology Committee of the Childrens Cancer Study Group

21 January 2018

1 reference

12 December 2020

Electrocardiographically gated blood-pool SPECT and left ventricular function: comparative value of 3 methods for ejection fraction and volume estimation.

1 reference

12 December 2020

Comparison of epirubicin and doxorubicin cardiotoxicity induced by low doses: evolution of the diastolic and systolic parameters studied by radionuclide angiography

1 reference

12 December 2020

Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction

1 reference

12 December 2020

The utility of cardiac biomarkers, tissue velocity and strain imaging, and cardiac magnetic resonance imaging in predicting early left ventricular dysfunction in patients with human epidermal growth factor receptor II-positive breast cancer treated

1 reference

12 December 2020

Annexin V imaging of acute doxorubicin cardiotoxicity (apoptosis) in rats

1 reference

12 December 2020

1 reference

12 December 2020

Trastuzumab-induced cardiac dysfunction

1 reference

12 December 2020

Planar imaging versus gated blood-pool SPECT for the assessment of ventricular performance: a multicenter study.

1 reference

12 December 2020

Detection of doxorubicin cardiotoxicity in patients with sarcomas by indium-111-antimyosin monoclonal antibody studies

1 reference

12 December 2020

Anthracycline cardiomyopathy monitored by morphologic changes

1 reference

12 December 2020

Effect of gender on cardiovascular risk stratification with ECG gated SPECT left ventricular volume indices and ejection fraction

1 reference

12 December 2020

[Chemotherapy and the heart]

1 reference

12 December 2020

American Society of Echocardiography Consensus Statement on the Clinical Applications of Ultrasonic Contrast Agents in Echocardiography

1 reference

12 December 2020

Hypertension in cancer patients.

1 reference

12 December 2020

Indium-111-antimyosin scintigraphy in the early detection of heart damage after anthracycline therapy in children

1 reference

12 December 2020

Potentiation of Doxorubicin cardiotoxicity by iron loading in a rodent model

1 reference

12 December 2020

Automatic quantification of left ventricular ejection fraction from gated blood pool SPECT

1 reference

12 December 2020

Early detection of doxorubicin cardiotoxicity: interest of Doppler echocardiographic analysis of left ventricular filling dynamics

1 reference

12 December 2020

Metaiodobenzylguanidine: evaluation of its potential as a tracer for monitoring doxorubicin cardiomyopathy

1 reference

12 December 2020

Subclinical cardiotoxic effects of anthracyclines as assessed by magnetic resonance imaging-a pilot study

1 reference

12 December 2020

Assessment of anthracycline-related myocardial adrenergic derangement by [123I]metaiodobenzylguanidine scintigraphy

1 reference

12 December 2020

Apoptosis and anthracycline cardiotoxicity

1 reference

12 December 2020

Reversibility of trastuzumab-related cardiotoxicity: new insights based on clinical course and response to medical treatment

1 reference

12 December 2020

Risk factors for development of daunorubicin cardiotoxicity

1 reference

12 December 2020

Prognostic value of cardiac metaiodobenzylguanidine imaging in patients with heart failure

1 reference

12 December 2020

Imaging for cardiotoxicity in cancer patients.

1 reference

12 December 2020

HFSA 2010 Comprehensive Heart Failure Practice Guideline

1 reference

12 December 2020

Usefulness of myocardial performance index and biochemical markers for early detection of anthracycline-induced cardiotoxicity in adults

1 reference

12 December 2020

Screening for long-term cardiac status during cancer treatment

1 reference

12 December 2020

Scintigraphic techniques for early detection of cancer treatment-induced cardiotoxicity

1 reference

12 December 2020

Indium-111-antimyosin and iodine-123-MIBG studies in early assessment of doxorubicin cardiotoxicity

1 reference

12 December 2020

Symptomatic cardiotoxicity with high-dose 5-fluorouracil infusion: a prospective study

1 reference

12 December 2020

Cardiac neurotransmission imaging.

1 reference

12 December 2020

10.1007/S12350-013-9707-1

Identifiers

DOI

1 reference

28 August 2017

1 reference